Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Aurobindo Phar Aurobindo Pharma Ltd. | BSE 1301.10 15.25 (1.19%) | NSE 1304.80 18.90 (1.47%) | Trade | Add

BSE Live

Mar 11, 16:01

1301.10 15.25 (1.19%)

Volume

AVERAGE VOLUME

5-Day

44,230

10-Day

60,421

30-Day

123,934

40,241

NSE Live

Mar 11, 15:58

1304.80 18.90 (1.47%)

Volume

AVERAGE VOLUME

5-Day

1,398,500

10-Day

1,606,221

30-Day

2,102,986

2,541,782

Financials

Print/Copy to Excel : Go

Cash Flow of Aurobindo Pharma (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
Net Profit/Loss Before Extraordinary Items And Tax	2,358.45	2,402.92	1,614.35	1,637.48	4,193.01
Net CashFlow From Operating Activities	1,645.79	1,714.80	1,821.16	3,726.71	2,994.41
Net Cash Used In Investing Activities	-2,065.90	-159.96	-3,459.68	-1,613.51	-2,648.73
Net Cash Used From Financing Activities	616.31	-1,837.03	1,719.48	-2,447.54	-27.94
Foreign Exchange Gains / Losses	15.74	8.38	0.48	-1.03	-1.51
Adjustments On Amalgamation Merger Demerger Others	0.00	0.00	0.00	0.00	0.00
Net Inc/Dec In Cash And Cash Equivalents	211.94	-273.81	81.44	-335.37	316.23
Cash And Cash Equivalents Begin of Year	83.32	357.13	48.21	383.58	67.35
Cash And Cash Equivalents End Of Year	295.26	83.32	129.65	48.21	383.58